May 08, 2023 7:00am EDT Societal CDMO Selected by Xequel Bio to Provide CDMO Services to Support Ongoing Clinical Development of iNexin™
May 03, 2023 4:05pm EDT Societal CDMO to Report Financial Results for First Quarter 2023 on May 10, 2023
Apr 12, 2023 7:00am EDT Societal CDMO Signs Multiple Project Expansion Agreements With Existing Customers
Apr 05, 2023 7:00am EDT Societal CDMO Selected by Longboard Pharmaceuticals to Provide CDMO Services to Support Clinical Development of LP352
Mar 20, 2023 7:00am EDT Societal CDMO Announces U.S. FDA Approval for Manufacturing of Commercial Tablet at Gainesville, Georgia Site
Feb 22, 2023 4:05pm EST Societal CDMO to Report Financial Results for Fourth Quarter and Year-End 2022 on March 1, 2023
Feb 01, 2023 7:00am EST Societal CDMO Highlights Growth of Existing Customer Business Through Signing of More Than $6 Million in Work Orders During Fourth Quarter of 2022